BRD4 and cancer: Bromodomain-containing protein 4 (BRD4), the most studied Bromodomain and Extraterminal (BET) family member of acetyl-lysine reader proteins, has become a highly pursued target in cancer and several CVDs (Lovén et al., 2013; Gillette and Hill, 2015; Lin and Du, 2020).